{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:06:28Z","timestamp":1792857988141,"version":"4.5.0"},"reference-count":108,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Inflammatory bowel diseases (IBDs) have been associated with a higher risk of colorectal cancer (CRC) development and chronic colonic inflammation seems to have a critical role in the pathogenesis of CRC in patients suffering from IBD. In respect to that, surveillance colonoscopy at regular intervals is recommended in patients with colitis. Objective: This review aims to explore the chemopreventive potential of a range of agents, including mesalazine, thiopurines, anti-TNF agents, statins, ursodeoxycholic acid, aspirin, folic acid, and nutraceuticals. Results: These agents target inflammation, oxidative stress, and oncogenic pathways, thereby offering the potential to reduce the risk of CRC in patients with IBD. Anti-TNF agents, such as infliximab and adalimumab, not only reduce colonic inflammation, but also play a protective role against CRC by lessening the carcinogenic effects associated with prolonged inflammatory processes. Furthermore, mesalazine and thiopurines have demonstrated established efficacy, while newer biologics, including interleukin inhibitors, show promising advancements. Although nutraceuticals and dietary interventions require further clinical validation, they offer additional possibilities for non-pharmacological prevention. Conclusion: Despite progress, knowledge gaps persist regarding the long-term safety, optimal dosing, and combined use of these agents. A significant reduction in the incidence of CRC in patients with IBD could be achieved by advancing chemoprevention and personalizing strategies.<\/jats:p>","DOI":"10.3390\/cancers17020229","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:40:40Z","timestamp":1736746840000},"page":"229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring Chemoprevention in Colorectal Cancer for Patients with Inflammatory Bowel Disease: Mechanisms of Action and Clinical Aspects"],"prefix":"10.3390","volume":"17","author":[{"given":"Fotios S.","family":"Fousekis","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Mpakogiannis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-5753","authenticated-orcid":false,"given":"Panagiotis","family":"Filis","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Skamnelos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-1160","authenticated-orcid":false,"given":"Dimitrios K.","family":"Christodoulou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Mauri","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos H.","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/10409238.2013.875514","article-title":"Sweasy J.B. Interplay between DNA repair and inflammation, and the link to cancer","volume":"49","author":"Kidane","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: A meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: A Scandinavian population-based cohort study","volume":"395","author":"Erichsen","year":"2020","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","article-title":"Colorectal cancer in Crohn\u2019s disease: A Scandinavian population-based cohort study","volume":"5","author":"Erichsen","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.v20.i22.6774","article-title":"Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis","volume":"20","author":"Scarpa","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_9","first-page":"2727","article-title":"Colorectal cancer and inflammatory bowel disease: Epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies","volume":"29","author":"Triantafillidis","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/14737140.2017.1283987","article-title":"Chemoprevention of colorectal cancer in inflammatory bowel disease","volume":"17","author":"Ehrlich","year":"2017","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJMcibr055457","article-title":"Colon Cancer\u2014Understanding How NSAIDs Work","volume":"354","author":"Clevers","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wang, Z., Li, S., Cao, Y., Tian, X., Zeng, R., Liao, D.-F., and Cao, D. (2016). Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer. Oxidative Med. Cell. Longev., 2016.","DOI":"10.1155\/2016\/9875298"},{"key":"ref_13","first-page":"3820","article-title":"TNF-\u03b1 promotes colon cancer cell migration and invasion by upregulating TROP-2","volume":"15","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.12.002","article-title":"IL-23 in inflammatory bowel diseases and colon cancer","volume":"45","author":"Neurath","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.7150\/ijbs.4614","article-title":"Interleukin-6\u2014A Key Regulator of Colorectal Cancer Development","volume":"8","author":"Waldner","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41389-023-00492-0","article-title":"Molecular mechanisms in colitis-associated colorectal cancer","volume":"12","author":"Zhou","year":"2023","journal-title":"Oncogenesis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/j.gastro.2011.12.004","article-title":"Field cancerization in the intestinal epithelium of patients with Crohn\u2019s ileocolitis","volume":"142","author":"Galandiuk","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_18","first-page":"11","article-title":"Precancer in ulcerative colitis: The role of the field effect and its clinical implications","volume":"39","author":"Baker","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cell.2020.06.036","article-title":"Somatic Evolution in Non-neoplastic IBD-Affected Colon","volume":"182","author":"Olafsson","year":"2020","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2016.04.001","article-title":"Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct from Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease","volume":"151","author":"Yaeger","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.gastro.2015.12.036","article-title":"Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers","volume":"150","author":"Robles","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Peng, S., Shen, L., Yu, X., Zhang, L., Xu, K., Xia, Y., Lanla, Z., Wu, J., and Luo, H. (2023). The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1200111"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pompili, S., Sferra, R., Gaudio, E., Viscido, A., Frieri, G., Vetuschi, A., and Latella, G. (2019). Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20164061"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/1940-6207.CAPR-08-0028","article-title":"Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer","volume":"1","author":"Khor","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Glorieux, C., Enriquez, C., Gonzalez, C., Aguirre-Martinez, G., and Buc Calderon, P. (2024). The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?. Antioxidants, 13.","DOI":"10.3390\/antiox13010070"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, F., Xiao, M., Hu, S., and Wang, M. (2024). Keap1-Nrf2 pathway: A key mechanism in the occurrence and development of cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1381467"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3748\/wjg.v25.i30.4148","article-title":"Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments","volume":"25","author":"Clarke","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on Inflammatory Bowel Disease and Malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.3748\/wjg.14.4434","article-title":"Molecular basis of the potential of mesalazine to prevent colorectal cancer","volume":"14","author":"Stolfi","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/s41416-021-01354-5","article-title":"5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: Implications for chemoprophylaxis in colorectal tumorigenesis","volume":"124","author":"Dixon","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sloka, J., Madej, M., and Strzalka-Mrozik, B. (2023). Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer. Molecules, 28.","DOI":"10.3390\/molecules28135081"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.ejca.2006.03.030","article-title":"5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death","volume":"42","author":"Fina","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: A critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2741\/3872","article-title":"Role of Rho GTPases and their regulators in cancer progression","volume":"16","author":"Rathinam","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: Weaving a tumorigenic web","volume":"11","author":"Grabocka","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1592\/phco.30.2.169","article-title":"Diverse effects of statins on angiogenesis: New therapeutic avenues","volume":"30","author":"Elewa","year":"2010","journal-title":"Pharmacotherapy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/1871520613666131129105035","article-title":"Statins and Cancer","volume":"14","author":"Vallianou","year":"2014","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_40","first-page":"1593","article-title":"Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin","volume":"39","author":"Wagner","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/gut.2009.190900","article-title":"Effect of statin therapy on colorectal cancer","volume":"59","author":"Bardou","year":"2010","journal-title":"Gut"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: The promise of precision chemoprevention","volume":"16","author":"Drew","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107396","DOI":"10.1016\/j.pharmthera.2019.107396","article-title":"Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy","volume":"203","author":"Goossens","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/CEJ.0b013e32834ef16f","article-title":"The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression","volume":"21","author":"Hanski","year":"2012","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_45","first-page":"3632","article-title":"Ursodeoxycholic acid suppresses epithelial-mesenchymal transition and cancer stem cell formation by reducing the levels of peroxiredoxin II and reactive oxygen species in pancreatic cancer cells","volume":"38","author":"Kim","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41420-021-00589-8","article-title":"Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47371","DOI":"10.1074\/jbc.M107098200","article-title":"Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-\u03baB-dependent Transcription by Ursodeoxycholic Acid","volume":"276","author":"Miura","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00432-017-2548-6","article-title":"The NF-\u03baB signalling pathway in colorectal cancer: Associations between dysregulated gene and miRNA expression","volume":"144","author":"Slattery","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/apt.14023","article-title":"Systematic review with meta-analysis: Use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"45","author":"Bonovas","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/apt.14436","article-title":"Systematic review with meta-analysis: Thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"47","author":"Lu","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ecco-jcc\/jjy006","article-title":"Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: A Systematic Review and Meta-analysis","volume":"12","author":"Zhu","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00384-020-03735-3","article-title":"Effects of 5-aminosalicylates or thiopurines on the progression of low-grade dysplasia in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"36","author":"Zeng","year":"2021","journal-title":"Int. J. Color. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/1940-6207.CAPR-09-0272","article-title":"Prevention of colitis-associated carcinogenesis with infliximab","volume":"3","author":"Kim","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/ibd\/izaa252","article-title":"Lower Rates of Colorectal Cancer in Patients with Inflammatory Bowel Disease Using Anti-TNF Therapy","volume":"27","author":"Alkhayyat","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: Results from a nationwide nested case-control study","volume":"106","author":"Baars","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/MIB.0000000000000457","article-title":"Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics: A Quebec Claims Database Study","volume":"21","author":"Kopylov","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jnci\/djr070","article-title":"Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations","volume":"103","author":"Lee","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/gut.2011.237495","article-title":"Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell \u2019stemness\u2019 via the bone morphogenetic protein pathway","volume":"60","author":"Kodach","year":"2011","journal-title":"Gut"},{"key":"ref_59","first-page":"255","article-title":"Statins and Colorectal Cancer\u2014A Systematic Review","volume":"128","author":"Dobrzycka","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00365521.2020.1731760","article-title":"Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: A population-based cohort study","volume":"55","author":"Mak","year":"2020","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5009\/gnl18178","article-title":"Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease","volume":"13","author":"Shah","year":"2019","journal-title":"Gut Liver"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cgh.2016.02.017","article-title":"Statin Use Is Associated with Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases","volume":"14","author":"Ananthakrishnan","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/cncr.25731","article-title":"Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use","volume":"117","author":"Samadder","year":"2011","journal-title":"Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"102182","DOI":"10.1016\/j.eclinm.2023.102182","article-title":"Statin use and risk of colorectal cancer in patients with inflammatory bowel disease","volume":"63","author":"Sun","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis","volume":"160","author":"Wijnands","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-med-060319-120913","article-title":"Aspirin in the Prevention of Colorectal Neoplasia","volume":"72","author":"Drew","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/bjs\/znad231","article-title":"Aspirin chemoprevention in colorectal cancer: Network meta-analysis of low, moderate, and high doses","volume":"110","author":"Shah","year":"2023","journal-title":"Br. J. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3748\/wjg.v22.i13.3679","article-title":"Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?","volume":"22","author":"Burr","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2413S","DOI":"10.1093\/jn\/132.8.2413S","article-title":"Folate status: Effects on pathways of colorectal carcinogenesis","volume":"132","author":"Choi","year":"2002","journal-title":"J. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1312626","DOI":"10.1155\/2018\/1312626","article-title":"Folic Acid Improves the Inflammatory Response in LPS-Activated THP-1 Macrophages","volume":"2018","author":"Samblas","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/em.20025","article-title":"Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies","volume":"44","author":"Kim","year":"2004","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/epi.20461","article-title":"Supra-physiological folic acid concentrations induce aberrant DNA methylation in normal human cells in vitro","volume":"7","author":"Charles","year":"2012","journal-title":"Epigenetics"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.clnu.2017.10.010","article-title":"Folic acid intake and folate status and colorectal cancer risk: A systematic review and meta-analysis","volume":"37","author":"Moazzen","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MCG.0000000000000498","article-title":"Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"51","author":"Burr","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol Use Is Associated with Lower Prevalence of Colonic Neoplasia in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S2210-7401(12)70022-0","article-title":"Chemoprevention of colorectal cancer with ursodeoxycholic acid: Pro","volume":"36","author":"Serfaty","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2011.10.020","article-title":"Risk for Colorectal Neoplasia in Patients with Colonic Crohn\u2019s Disease and Concomitant Primary Sclerosing Cholangitis","volume":"10","author":"Braden","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.2011.04966.x","article-title":"High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia","volume":"35","author":"Lindstrom","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-Dose Ursodeoxycholic Acid Is Associated with the Development of Colorectal Neoplasia in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/MIB.0b013e318286fa61","article-title":"Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease","volume":"19","author":"Singh","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10620-013-2772-0","article-title":"Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis","volume":"58","author":"Hansen","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.apsb.2014.04.002","article-title":"Nutraceuticals as potential therapeutic agents for colon cancer: A review","volume":"4","author":"Kuppusamy","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Islam, M.R., Akash, S., Rahman, M.M., Nowrin, F.T., Akter, T., Shohag, S., Rauf, A., Aljohani, A.S.M., and Simal-Gandara, J. (2022). Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chem. -Biol. Interact., 368.","DOI":"10.1016\/j.cbi.2022.110170"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/healthcare3020364","article-title":"Does Whole Grain Consumption Alter Gut Microbiota and Satiety?","volume":"3","author":"Cooper","year":"2015","journal-title":"Healthcare"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0029665123003671","article-title":"The effects of whole grain cereals on tryptophan metabolism and intestinal barrier function: Underlying factors of health impact","volume":"83","author":"Liikonen","year":"2024","journal-title":"Proc. Nutr. Soc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ismej.2012.104","article-title":"Gut microbiome composition is linked to whole grain-induced immunological improvements","volume":"7","author":"Martinez","year":"2013","journal-title":"ISME J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1039\/D1FO00858G","article-title":"Effects of cereal fibers on short-chain fatty acids in healthy subjects and patients: A meta-analysis of randomized clinical trials","volume":"12","author":"Bai","year":"2021","journal-title":"Food Funct."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12672-024-01313-5","article-title":"Short-chain fatty acids play a positive role in colorectal cancer","volume":"15","author":"Liu","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zhou, D.D., Li, J., Xiong, R.G., Saimaiti, A., Huang, S.Y., Wu, S.X., Shang, A., Zhao, C.N., Gan, R.Y., and Li, H.B. (2022). Bioactive Compounds, Health Benefits and Food Applications of Grape. Foods, 11.","DOI":"10.3390\/foods11182755"},{"key":"ref_93","first-page":"1","article-title":"Anticancer Effects of Grape Seed Extract on Human Cancers: A Review","volume":"S8","author":"Dinicola","year":"2014","journal-title":"J. Carcinog. Mutagen."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3892\/ijmm.2012.1147","article-title":"Grape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1","volume":"30","author":"Huang","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Luo, Q., Zhou, P., Chang, S., Huang, Z., and Zeng, X. (2023). Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-32457-z"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1074\/mcp.RA118.000752","article-title":"Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/01635581.2010.510259","article-title":"Colorectal cancer: Chemopreventive role of curcumin and resveratrol","volume":"62","author":"Patel","year":"2010","journal-title":"Nutr. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Pricci, M., Girardi, B., Giorgio, F., Losurdo, G., Ierardi, E., and Di Leo, A. (2020). Curcumin and Colorectal Cancer: From Basic to Clinical Evidences. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072364"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Ojo, O.A., Adeyemo, T.R., Rotimi, D., Batiha, G.E., Mostafa-Hedeab, G., Iyobhebhe, M.E., Elebiyo, T.C., Atunwa, B., Ojo, A.B., and Lima, C.M. (2022). Anticancer Properties of Curcumin Against Colorectal Cancer: A Review. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.881641"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1615\/OncoTherap.2022044575","article-title":"Therapeutic Applications of Curcumin and Derivatives in Colorectal Cancer","volume":"9","author":"Lambring","year":"2022","journal-title":"Onco Ther."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Celiberto, F., Aloisio, A., Girardi, B., Pricci, M., Iannone, A., Russo, F., Riezzo, G., D\u2019Attoma, B., Ierardi, E., and Losurdo, G. (2023). Fibres and Colorectal Cancer: Clinical and Molecular Evidence. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713501"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e11678","DOI":"10.1097\/MD.0000000000011678","article-title":"Dietary fiber intake and risks of proximal and distal colon cancers: A meta-analysis","volume":"97","author":"Ma","year":"2018","journal-title":"Medicine"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/apt.16785","article-title":"Review article: Emerging drug therapies in inflammatory bowel disease","volume":"55","author":"Grossberg","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.7150\/ijbs.46651","article-title":"The Role of Interleukins in Colorectal Cancer","volume":"16","author":"Li","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3892\/ol.2012.739","article-title":"IL-23 directly enhances the proliferative and invasive activities of colorectal carcinoma","volume":"4","author":"Suzuki","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/s41467-021-25393-x","article-title":"Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape","volume":"12","author":"Hicks","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jgh.15806","article-title":"Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy","volume":"37","author":"Hasan","year":"2022","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:27:25Z","timestamp":1759919245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,12]]},"references-count":108,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["cancers17020229"],"URL":"https:\/\/doi.org\/10.3390\/cancers17020229","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,12]]}}}